Genetically Engineered Babies Are Banned. Tech Titans Are Trying to Make One Anyway.
By Emily Glazer, Katherine Long, Amy Dockser Marcus,
The Wall Street Journal
| 11. 08. 2025
Startups funded by some of the most powerful billionaires in Silicon Valley are pushing the boundaries of reproductive genetics, hoping to prevent diseases as well as improve the chances for a high IQ and other preferred traits
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called Preventive—has been quietly preparing what would amount to a biological first. They are working toward creating a child born from an embryo edited to prevent a hereditary disease. In recent months, executives at the company privately said a couple with a genetic disease had been identified who was interested in participating, according to people familiar with the conversations.
Gene-editing technologies now in use for treatment after birth allow scientists to cut, edit and insert DNA, but using the process in sperm, eggs or embryos is far more controversial and has prompted calls by scientists for a global moratorium until the ethical and scientific questions get resolved. Editing genes in embryos with the intention of creating babies from them is banned in the U.S. and many countries.
Preventive has been searching for places to experiment where embryo editing is allowed, including...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...